China Universal Asset Management Company’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Buy |
17,147
+85
| +0.5% | +$784 | 0.01% | 330 |
|
|
2025
Q1 | $146K | Sell |
17,062
-918
| -5% | -$7.88K | 0.01% | 337 |
|
|
2024
Q4 | $193K | Buy |
17,980
+1,671
| +10% | +$17.9K | 0.02% | 327 |
|
|
2024
Q3 | $92.6K | Buy |
16,309
+6,366
| +64% | +$36.2K | 0.01% | 361 |
|
|
2024
Q2 | $42K | Sell |
9,943
-5,830
| -37% | -$24.6K | 0.01% | 368 |
|
|
2024
Q1 | $80.3K | Buy |
15,773
+6,275
| +66% | +$31.9K | 0.01% | 390 |
|
|
2023
Q4 | $88.4K | Buy |
9,498
+7,395
| +352% | +$68.8K | 0.02% | 299 |
|
|
2023
Q3 | $13.8K | Buy |
2,103
+1,044
| +99% | +$6.84K | ﹤0.01% | 324 |
|
|
2023
Q2 | $8.61K | Buy |
1,059
+2
| +0.2% | +$16 | ﹤0.01% | 328 |
|
|
2023
Q1 | $9.06K | Buy |
1,057
+265
| +33% | +$2.27K | ﹤0.01% | 303 |
|
|
2022
Q4 | $7.33K | Buy |
792
+62
| +8% | +$574 | ﹤0.01% | 254 |
|
|
2022
Q3 | $8K | Buy |
+730
| New | +$8K | ﹤0.01% | 222 |
|